Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease

Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease

Abstract Buerger's disease or thromboangiitis obliterans is a type of obstructive vascular diseases categorized as vasculitis and usually present in 95% of young smoker men. The main pathogenetic mechanism is interplay between immune system and inflammation. Earlier our phase II study has shown...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pawan Kumar Gupta, Santanu Dutta, Sanjay Kala, Muralikrishna Nekkanti, Sanjay C. Desai, Subhendu S. Mahapatra, Anita Dhar, Radhakrishnan Raju, Rajkumar M., Arunanshu Behera, Shivashankar P., N.S. Raviraja, Pachaiyappan Viswanathan, Mithun Chandrashekar, Charan Thej, Prasanth K.V., Jijy Abraham, Hema Boggarapu, K. Udaykumar
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
angiogenesis
ankle brachial pressure index
critical limb ischemia
mesenchymal stromal cells
rest pain score
Rutherford III‐5 or III‐6
Medicine (General)
R5-920
Cytology
QH573-671
Acceso en línea:https://doaj.org/article/d9172901775d4f848f334111134a5c7c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/d9172901775d4f848f334111134a5c7c

Ejemplares similares